Biodefense - Global Market Outlook (2018-2027)

Home > Market Research Reports > Aerospace & Defense

	Market Research Report Biodefense - Global Market Outlook (2018-2027)
Published by	Stratistics Market Research Consulting			Product code	932672
Published	March 1, 2020	Content info	194 Pages Delivery time: 2-3 business days
Price	PDF (Single User License) USD 4150 PDF (2-5 User License) USD 5250 PDF (Site License) USD 6350 PDF (Global Site License) USD 7500

Description

According to Stratistics MRC, the Global Biodefense market is accounted for $5.47 billion in 2018 and is expected to reach $8.85 billion by 2027 growing at a CAGR of 5.5% during the forecast period. Some of the key factors propelling the market growth are rising investment by the governments in developed countries and technological advancements. However, less penetration in developing and underdeveloped countries is the restraining factor for the growth of the market.

Biodefense constitutes the use of medical measures, to protect individuals against bioterrorism, including interventions, such as drugs and vaccinations. Furthermore, there is an improvement, in terms of research and public health preparations, in order to defend against biological attacks. There is an increasing awareness regarding synthetic biology, mainly for using biological organisms, to reduce the burden of diseases, especially for improving agricultural yields.

By product, vaccines segment is segregated into anthrax, antibiotics, botulism, E-Bola, eye shield, immunization vaccine, nuclear/radiation, smallpox, and zika. Anthrax segment is expected to grow at the significant market share during the forecast period owing to the increased investment on production and stockpiling of anthrax vaccine by government agencies such as the Centre for Disease Control (CDC) and Department of Defense among others.

On the basis of geography, North America is anticipated to hold considerable market share during the forecast period due to increase spending by the governments across the globe to develop and store sufficient vaccines against anthrax and U.S government implementing the number of initiatives that assist them in reinforcing security against biological threats.

Some of the key players in Biodefense Market include Xoma Corporation, Altimmune Inc, Bavarian Nordic, Cleveland BioLabs, Dynavax Technologies Inc, Dynport Vaccine Company LLC (DVC), Elusys Therapeutics, Emergent BioSolutions Inc, Ichor Medical Systems, Nanotherapeutics, Ology Bioservices, PathSensors Inc and Siga Technologies Inc.

Products Covered:

Vaccines
Biothreat detection devices

Sales Channels Covered:

Direct Sales
In Direct Sales

Applications Covered:

Military
Civilian

Regions Covered:

North America

US
Canada
Mexico

Europe

Germany
France
Italy
UK
Spain
Rest of Europe

Asia Pacific

Japan
China
India
Australia
New Zealand
Rest of Asia Pacific

South America

Argentina
Brazil
Chile
Rest of South America

Middle East & Africa

Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling

Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)

Regional Segmentation

Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)

Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology

2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach

2.5 Research Sources

2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Biodefense Market, By Product

5.1 Introduction
5.2 Vaccines

5.2.1 Anthrax
5.2.2 Antibiotics
5.2.3 Botulism
5.2.4 E-Bola
5.2.5 Eye Shield
5.2.6 Immunization Vaccine
5.2.7 Nuclear/Radiation
5.2.8 Smallpox
5.2.9 Zika

5.3 Biothreat detection devices

5.3.1 Assays and Reagents
5.3.2 Detectors/triggering devices
5.3.3 Identifiers
5.3.4 Samplers

6 Global Biodefense Market, By Sales Channel

6.1 Introduction
6.2 Direct Sales
6.3 In Direct Sales

7 Global Biodefense Market, By Application

7.1 Introduction
7.2 Military
7.3 Civilian

8 Global Biodefense Market, By Geography

8.1 Introduction
8.2 North America

8.2.1 US
8.2.2 Canada
8.2.3 Mexico

8.3 Europe

8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe

8.4 Asia Pacific

8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific

8.5 South America

8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America

8.6 Middle East & Africa

8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Xoma Corporation
10.2 Altimmune Inc
10.3 Bavarian Nordic
10.4 Cleveland BioLabs
10.5 Dynavax Technologies Inc
10.6 Dynport Vaccine Company LLC (DVC)
10.7 Elusys Therapeutics
10.8 Emergent BioSolutions Inc
10.9 Ichor Medical Systems
10.10 Nanotherapeutics
10.11 Ology Bioservices
10.12 PathSensors Inc
10.13 Siga Technologies Inc

List of Tables

Table 1 Global Biodefense Market Outlook, By Region (2017-2027) ($MN)
Table 2 Global Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
Table 3 Global Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
Table 4 Global Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
Table 5 Global Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
Table 6 Global Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
Table 7 Global Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
Table 8 Global Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
Table 9 Global Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
Table 10 Global Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
Table 11 Global Biodefense Market Outlook, By Zika (2017-2027) ($MN)
Table 12 Global Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
Table 13 Global Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
Table 14 Global Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
Table 15 Global Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
Table 16 Global Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
Table 17 Global Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
Table 18 Global Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
Table 19 Global Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
Table 20 Global Biodefense Market Outlook, By Application (2017-2027) ($MN)
Table 21 Global Biodefense Market Outlook, By Military (2017-2027) ($MN)
Table 22 Global Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
Table 23 North America Biodefense Market Outlook, By Country (2017-2027) ($MN)
Table 24 North America Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
Table 25 North America Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
Table 26 North America Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
Table 27 North America Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
Table 28 North America Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
Table 29 North America Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
Table 30 North America Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
Table 31 North America Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
Table 32 North America Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
Table 33 North America Biodefense Market Outlook, By Zika (2017-2027) ($MN)
Table 34 North America Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
Table 35 North America Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
Table 36 North America Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
Table 37 North America Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
Table 38 North America Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
Table 39 North America Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
Table 40 North America Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
Table 41 North America Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
Table 42 North America Biodefense Market Outlook, By Application (2017-2027) ($MN)
Table 43 North America Biodefense Market Outlook, By Military (2017-2027) ($MN)
Table 44 North America Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
Table 45 Europe Biodefense Market Outlook, By Country (2017-2027) ($MN)
Table 46 Europe Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
Table 47 Europe Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
Table 48 Europe Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
Table 49 Europe Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
Table 50 Europe Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
Table 51 Europe Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
Table 52 Europe Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
Table 53 Europe Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
Table 54 Europe Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
Table 55 Europe Biodefense Market Outlook, By Zika (2017-2027) ($MN)
Table 56 Europe Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
Table 57 Europe Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
Table 58 Europe Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
Table 59 Europe Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
Table 60 Europe Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
Table 61 Europe Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
Table 62 Europe Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
Table 63 Europe Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
Table 64 Europe Biodefense Market Outlook, By Application (2017-2027) ($MN)
Table 65 Europe Biodefense Market Outlook, By Military (2017-2027) ($MN)
Table 66 Europe Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
Table 67 Asia Pacific Biodefense Market Outlook, By Country (2017-2027) ($MN)
Table 68 Asia Pacific Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
Table 69 Asia Pacific Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
Table 70 Asia Pacific Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
Table 71 Asia Pacific Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
Table 72 Asia Pacific Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
Table 73 Asia Pacific Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
Table 74 Asia Pacific Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
Table 75 Asia Pacific Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
Table 76 Asia Pacific Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
Table 77 Asia Pacific Biodefense Market Outlook, By Zika (2017-2027) ($MN)
Table 78 Asia Pacific Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
Table 79 Asia Pacific Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
Table 80 Asia Pacific Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
Table 81 Asia Pacific Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
Table 82 Asia Pacific Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
Table 83 Asia Pacific Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
Table 84 Asia Pacific Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
Table 85 Asia Pacific Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
Table 86 Asia Pacific Biodefense Market Outlook, By Application (2017-2027) ($MN)
Table 87 Asia Pacific Biodefense Market Outlook, By Military (2017-2027) ($MN)
Table 88 Asia Pacific Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
Table 89 South America Biodefense Market Outlook, By Country (2017-2027) ($MN)
Table 90 South America Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
Table 91 South America Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
Table 92 South America Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
Table 93 South America Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
Table 94 South America Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
Table 95 South America Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
Table 96 South America Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
Table 97 South America Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
Table 98 South America Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
Table 99 South America Biodefense Market Outlook, By Zika (2017-2027) ($MN)
Table 100 South America Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
Table 101 South America Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
Table 102 South America Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
Table 103 South America Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
Table 104 South America Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
Table 105 South America Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
Table 106 South America Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
Table 107 South America Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
Table 108 South America Biodefense Market Outlook, By Application (2017-2027) ($MN)
Table 109 South America Biodefense Market Outlook, By Military (2017-2027) ($MN)
Table 110 South America Biodefense Market Outlook, By Civilian (2017-2027) ($MN)
Table 111 Middle East & Africa Biodefense Market Outlook, By Country (2017-2027) ($MN)
Table 112 Middle East & Africa Biodefense Market Outlook, By Vaccines (2017-2027) ($MN)
Table 113 Middle East & Africa Biodefense Market Outlook, By Anthrax (2017-2027) ($MN)
Table 114 Middle East & Africa Biodefense Market Outlook, By Antibiotics (2017-2027) ($MN)
Table 115 Middle East & Africa Biodefense Market Outlook, By Botulism (2017-2027) ($MN)
Table 116 Middle East & Africa Biodefense Market Outlook, By E-Bola (2017-2027) ($MN)
Table 117 Middle East & Africa Biodefense Market Outlook, By Eye Shield (2017-2027) ($MN)
Table 118 Middle East & Africa Biodefense Market Outlook, By Immunization Vaccine (2017-2027) ($MN)
Table 119 Middle East & Africa Biodefense Market Outlook, By Nuclear/Radiation (2017-2027) ($MN)
Table 120 Middle East & Africa Biodefense Market Outlook, By Smallpox (2017-2027) ($MN)
Table 121 Middle East & Africa Biodefense Market Outlook, By Zika (2017-2027) ($MN)
Table 122 Middle East & Africa Biodefense Market Outlook, By Biothreat detection devices (2017-2027) ($MN)
Table 123 Middle East & Africa Biodefense Market Outlook, By Assays and Reagents (2017-2027) ($MN)
Table 124 Middle East & Africa Biodefense Market Outlook, By Detectors/triggering devices (2017-2027) ($MN)
Table 125 Middle East & Africa Biodefense Market Outlook, By Identifiers (2017-2027) ($MN)
Table 126 Middle East & Africa Biodefense Market Outlook, By Samplers (2017-2027) ($MN)
Table 127 Middle East & Africa Biodefense Market Outlook, By Sales Channel (2017-2027) ($MN)
Table 128 Middle East & Africa Biodefense Market Outlook, By Direct Sales (2017-2027) ($MN)
Table 129 Middle East & Africa Biodefense Market Outlook, By In Direct Sales (2017-2027) ($MN)
Table 130 Middle East & Africa Biodefense Market Outlook, By Application (2017-2027) ($MN)
Table 131 Middle East & Africa Biodefense Market Outlook, By Military (2017-2027) ($MN)
Table 132 Middle East & Africa Biodefense Market Outlook, By Civilian (2017-2027) ($MN)